Chris Calise

Insider Reports History

Location
Miami Beach, FL
Signature
/s/ Christopher Calise
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Chris Calise:

Company Role Class Num Shares Value Price $ Report Date Ownership
Coeptis Therapeutics Holdings, Inc. Director Common stock 368,741 $5,302,495 $14.38 11 Feb 2026 Direct
Coeptis Therapeutics Holdings, Inc. Director Non-qualified Stock Options (right to buy) 8,950 04 Mar 2025 Direct

Insider Reports Filed by Chris Calise

Symbol Company Period Transactions Value $ Form Type Role Filing Time
COEP Coeptis Therapeutics Holdings, Inc. 11 Feb 2026 2 +$60,192 4 Director 13 Feb 2026, 17:00
COEP Coeptis Therapeutics Holdings, Inc. 04 Mar 2025 1 $0 4 Director 06 Mar 2025, 17:26
COEP Coeptis Therapeutics Holdings, Inc. 23 Aug 2023 2 +$10,879 4 Director 31 Aug 2023, 16:01
COEP Coeptis Therapeutics Holdings, Inc. 27 Jan 2023 1 $0 4 Director 31 Jan 2023, 09:50